Statistics

Total Visits

Views
The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial 73
The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial 37

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial 0 7 0 2 1 5 0

File Downloads

Views

Top Country Views

Views
United States 52
China 18
Vietnam 12
Netherlands 9
Australia 3
France 2
Canada 1
Germany 1
Israel 1

Top City Views

Views
Ashburn 16
Fairfield 14
Hanoi 12
Rotterdam 8
New York 6
Zhengzhou 3
Cambridge 2
Des Moines 2
Adelaide 1
Augusta 1